Streetbeat News

Acquisitions Mergers

GCT

GigaCloud Technology has acquired a 100% equity interest in Apexis, Inc. for $10 million, expanding its business and potentially increasing its market share.

Portfolio Pulse from Benzinga Newsdesk

November 16, 2023 | 12:40 pm

Tradeweb Markets has signed a definitive agreement to acquire r8fin for an undisclosed sum. The acquisition is expected to enhance Tradeweb's offerings and market position.

Portfolio Pulse from Benzinga Newsdesk

November 16, 2023 | 12:35 pm

EADSF

EADSY

RYCEF

RYCEY

Airbus SE (OTC:EADSF) secured an order for 15 additional A350-900s from Emirates Airlines, bringing the total order to 65 aircraft. This follows a public dispute at the Dubai Airshow where Emirates criticized Rolls-Royce Holdings PLC (OTC:RYCEY)(OTC:RYCEF) over engine durability issues. The deal is seen as a compromise after the dispute. Airbus also made sales to Ethiopian Airlines and EGYPTAIR this month. Airbus shares (OTC:EADSY) closed down 1.14% at $35.43.

Portfolio Pulse from Lekha Gupta

November 16, 2023 | 12:34 pm

VNET

VNET Group, Inc. has received a strategic investment of $299 million from Shandong Hi-Speed Holdings Group. This investment could bolster VNET's financial position and potentially lead to future collaboration between the two entities.

Portfolio Pulse from Benzinga Newsdesk

November 16, 2023 | 12:21 pm

WAVD

WaveDancer, Inc. (WAVD) has entered into a definitive merger agreement with Firefly Neuroscience in an all-stock transaction. This strategic move aims to expand WaveDancer's portfolio and market presence by integrating Firefly's expertise in the neuroscience sector.

Portfolio Pulse from Benzinga Newsdesk

November 16, 2023 | 12:18 pm

FIXX

Q32 Bio and Homology Medicines have agreed to merge in an all-stock transaction, with the combined entity to focus on Q32 Bio's autoimmune and inflammatory disease candidates. Post-merger, the company will be named Q32 Bio, based in Waltham, Massachusetts, and will trade on Nasdaq under the ticker 'QTTB'.

Portfolio Pulse from Benzinga Newsdesk

November 16, 2023 | 12:07 pm

RNW

Renew Power (RNW) has successfully commissioned its first interstate transmission scheme project. This milestone follows investments from Norfund and KLP, which are expected to bolster the company's growth and capabilities in the renewable energy sector.

Portfolio Pulse from Benzinga Newsdesk

November 16, 2023 | 12:02 pm

GSK

HLN

JNJ

KVUE

SNY

Sanofi SA (NYSE:SNY) is considering spinning off its consumer health division, potentially valued over $20 billion, with Rothschild & Co. advising on the process. The spinoff, expected by Q4 2024, aims to focus Sanofi on innovative medicines and vaccines. Major buyout firms are interested in the division, which includes products like Phytoxil, Icy Hot, and Dulcolax. The move follows similar actions by GSK Plc (NYSE:GSK) and Johnson & Johnson (NYSE:JNJ), who spun off Haleon Plc (NYSE:HLN) and Kenvue Inc (NYSE:KVUE). Sanofi's shares dropped 0.68% in premarket trading.

Portfolio Pulse from Vandana Singh

November 16, 2023 | 11:58 am

MET

MetLife has completed a risk transfer transaction with Global Atlantic Financial Group, which will expedite the run-off of MetLife Holdings. This transaction involves approximately $19 billion of statutory reserves.

Portfolio Pulse from Benzinga Newsdesk

November 16, 2023 | 11:53 am

AZN

BMY

MRK

RHHBY

The FDA has approved Bristol Myers Squibb's Augtyro for treating ROS1-positive non-small cell lung cancer. Acquired through a $4.1 billion deal with Turning Point Therapeutics, Augtyro demonstrated a 79% objective response rate in TKI-naïve patients. It enters a competitive market with existing treatments from Roche, Merck, and AstraZeneca. Augtyro will be available in the U.S. in mid-December 2023, and BMY shares closed at $51.57.

Portfolio Pulse from Vandana Singh

November 16, 2023 | 11:48 am